Subsequent ROC curve analysis on basis of validation cohort specific CpGs revealed significant results for a combination of SPAG6 and PER1, achieving breast cancer detection with 25% sensitivity (Supplementary Table 2). This evidence concerns the gene SPAG6 and breast carcinoma.